This study highlights how NAD+ levels decline in both mouse and human Alzheimers brain samples and how boosting NAD+ may prevent and reverse neurodegeneration and cognitive decline
There is, per ClinicalTrials.gov, no completed human efficacy trial for 5-Amino-1MQ
ZMT (6 capsules nightly) Combines zinc, magnesium, ashwagandha, and other adaptogens to promote deep sleep, testosterone production, and cortisol regulation
Homocysteine Lowering B Vitamins: B12 Shots & B12 Injections: Investigating the Good, Bad, and Alternative
Based on preclinical (animal and cellular) data only, inhibition of NNMT by 5-Amino-1MQ is theorised to: Raise intracellular NAD+ levels Activate SIRT1 and other sirtuins (proteins linked to metabolic regulation) Reduce fat cell (adipocyte) size and proliferation Improve insulin sensitivity These effects have been demonstrated in mouse models (Neelakantan et al., 2019), but robust human clinical trial data are currently absent